COVID-19 Study in the U.S. Awarded to GCT
Global Clinical Trials has been selected to conduct a Phase I study in COVID-19 patients. The Investigational Medicinal Product is a nasal antiseptic formulation designed to ease the symptoms and reduce SAR COVID-19 viral load. It will be available over the counter for anyone in need.
The project is now in active start up with GCT medical writing team developing the needed documentation. GCT is responsible for the full-service clinical support including project and site management, medical writing, data management and biostatistics.
Updated: March 11, 2021